3. Fatty liver disease after pancreatoduodenectomy and total pancreatectomy

Authors

DOI:

https://doi.org/10.35805/BSK2025I003

Downloads

Abstract

Pancreatoduodenectomy is the only treatment method for patients with pancreatic head and periampullary region tumors. It is known that some long-lived patients develop exocrine pancreatic insufficiency after surgery. One of the consequences of exocrine pancreatic insufficiency is fatty liver disease, which has been reported to occur in 7.8% to 40.0% of patients after pancreatoduodenectomy. We reported two clinical cases of patients who underwent pancreatoduodenectomy and total pancreatectomy for pancreatic head cancer and intraductal papillary mucinous neoplasm of the main pancreatic duct. After surgery, they developed rapidly progressive fatty liver disease with no history of liver disease, leading to death from liver failure 20 days and 3 months after surgery. Severe malnutrition caused by exocrine pancreatic insufficiency, postoperative eating disorders, and exacerbation of diabetes mellitus were the main factors contributing to the rapid deterioration of the condition. This clinical case highlights the possibility of developing life-threatening fatty liver disease with severe fibrosis after pancreatoduodenectomy and total pancreatectomy. Careful monitoring of liver status, regular nutritional assessment of patients, prophylactic replacement of pancreatic enzymes, and ensuring adequate nutrition are important.

Keywords

pancreatoduodenectomy, fatty liver disease, pancreatic cancer, liver failure, exocrine pancreatic insufficiency

References

  1. Strobel O, Neoptolemos J, Jager D, Buchler MW. Optimizing the out-comes of pancreatic cancer surgery. Nat Rev Clin Oncol. Jan 2019;16(1):11-26. doi:10.1038/s41571-018-0112-1
  2. Serrano PE, Cleary SP, Dhani N, et al. Improved long-term outcomes after resection of pancreatic adeno-carcinoma: a comparison between two time periods. Ann Surg Oncol. Apr 2015;22(4):1160-7. doi:10.1245/s10434-014-4196-2
  3. Sato T, Matsuo Y, Shiga K, Morimoto M, Miyai H, Takeyama H. Factors that predict the occurrence of and recov-ery from non-alcoholic fatty liver dis-ease after pancreatoduodenectomy. Surgery. Aug 2016;160(2):318-30. doi:10.1016/j.surg.2016.04.009
  4. Bartel MJ, Asbun H, Stauffer J, Rai-mondo M. Pancreatic exocrine insuf-ficiency in pancreatic cancer: A review of the literature. Dig Liver Dis. Dec 2015;47(12):1013-20. doi:10.1016/j.dld.2015.06.015
  5. Sabater L, Ausania F, Bakker OJ, et al. Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pan-creatic Surgery. Ann Surg. Dec 2016;264(6):949-958. doi:10.1097/SLA.0000000000001732
  6. Kumar TK, Tewari M, Shukla SK, Mishra SP. Pancreatic exocrine in-sufficiency occurs in most patients following pancreaticoduodenec-tomy. Indian J Cancer. Oct-Dec 2021;58(4):511-517. doi:10.4103/ijc.IJC_764_18
  7. Idilman IS, Ozdeniz I, Karcaaltincaba M. Hepatic Steatosis: Etiology, Pat-terns, and Quantification. Semin Ul-trasound CT MR. Dec 2016;37(6):501-510. doi:10.1053/j.sult.2016.08.003
  8. Roeyen G, Jansen M, Chapelle T, et al. Diabetes mellitus and pre-diabe-tes are frequently undiagnosed and underreported in patients referred for pancreatic surgery. A prospec-tive observational study. Pancre-atology. Jul-Aug 2016;16(4):671-6. doi:10.1016/j.pan.2016.04.032
  9. Imaoka H, Mizuno N, Hara K, et al. Evaluation of Modified Glasgow Prognostic Score for Pancreatic Can-cer: A Retrospective Cohort Study. Pancreas. Feb 2016;45(2):211-7. doi:10.1097/MPA.0000000000000446
  10. Duarte N, Coelho IC, Patar-rao RS, Almeida JI, Penha-Gon-calves C, Macedo MP. How In-flammation Impinges on NAFLD: A Role for Kupffer Cells. Biomed Res Int. 2015;2015:984578. doi:10.1155/2015/984578
  11. Kato H, Asano Y, Ito M, et al. Significant positive impact of duodenum-pre-serving pancreatic head resection on the prevention of postoperative non-alcoholic fatty liver disease and acute cholangitis. Ann Gastroenterol Surg. Nov 2022;6(6):851-861. doi:10.1002/ags3.12593
  12. Brown JA, Jung JP, Zenati MS, et al. Video review reveals technical fac-tors predictive of biliary stricture and cholangitis after robotic pancreati-coduodenectomy. HPB (Oxford). Jan 2021;23(1):144-153. doi:10.1016/j
  13. Beger HG, Mayer B, Poch B. Resec-tion of the duodenum causes long-term endocrine and exocrine dys-function after Whipple procedure for benign tumors - Results of a system-atic review and meta-analysis. HPB (Oxford). Jun 2020;22(6):809-820. doi:10.1016/j.hpb.2019.12.016
  14. Luu C, Thapa R, Rose T, et al. Iden-tification of nonalcoholic fatty liver disease following pancreatectomy for noninvasive intraductal papil-lary mucinous neoplasm. Int J Surg. Oct 2018;58:46-49. doi:10.1016/j.ijsu.2018.09.002
  15. Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. May 2019;15(5):261-273. doi:10.1038/s41574-019-0156-z
  16. Takada T, Takikawa H, Sawada N, et al. Cholangio-venous reflux of biliary contents through paracellular path-ways between hepatocytes in patients with acute cholangitis. J Hepatobili-ary Pancreat Sci. Jun 2021;28(6):508-514. doi:10.1002/jhbp.937
  17. Kobayashi N, Kumada T, Toyoda H, et al. Ability of Cytokeratin-18 Frag-ments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalco-holic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Pa-tients. Dig Dis. 2017;35(6):521-530. doi:10.1159/000480142
  18. Sun W, Cui H, Li N, et al. Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of ad-vanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study. Hepatol Res. Aug 2016;46(9):862-70. doi:10.1111/hepr.12647
  19. Satoi S, Sho M, Yanagimoto H, et al. Do pancrelipase delayed-release cap-sules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A random-ized controlled trial. J Hepatobiliary Pancreat Sci. Mar 2016;23(3):167-73. doi:10.1002/jhbp.318
  20. Hong SS, Chong JU, Hwang HK, Lee WJ, Kang CM. Laparoscopic pan-creaticoduodenectomy reduces in-cidence of clinically relevant post-operative pancreatic fistula in soft pancreas with a smaller than 2 mm pancreatic duct. Surg Endosc. Dec 2021;35(12):7094-7103. doi:10.1007/s00464-020-08226-8
  21. Cools KS, Sanoff HK, Kim HJ, Yeh JJ, Stitzenberg KB. Impact of neo-adjuvant therapy on postoperative outcomes after pancreaticodu-odenectomy. J Surg Oncol. Sep 2018;118(3):455-462. doi:10.1002/jso.25183
  22. Okabe H, Yamashita YI, Inoue R, et al. Postoperative nonalcoholic fatty liver disease is correlated with mal-nutrition leading to an unpreferable clinical course for pancreatic can-cer patients undergoing pancreati-coduodenectomy. Surg Today. Feb 2020;50(2):193-199. doi:10.1007/s00595-019-01866-x
  23. Verma V, Li J, Lin C. Neoadjuvant Therapy for Pancreatic Cancer: Systematic Review of Postopera-tive Morbidity, Mortality, and Com-plications. Am J Clin Oncol. Jun 2016;39(3):302-13. doi:10.1097/COC.0000000000000278
  24. Latchana N, Davis L, Coburn NG, et al. Population-based study of the im-pact of surgical and adjuvant therapy at the same or a different institution on survival of patients with pancre-atic adenocarcinoma. BJS Open. Feb 2019;3(1):85-94. doi:10.1002/bjs5.50115
  25. Nagakawa Y, Sahara Y, Hosokawa Y, et al. Clinical Impact of Neoadju-vant Chemotherapy and Chemora-diotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery. Ann Surg Oncol. Jun 2019;26(6):1629-1636. doi:10.1245/s10434-018-07131-8
  26. Javed AA, Wright MJ, Siddique A, et al. Outcome of Patients with Border-line Resectable Pancreatic Cancer in the Contemporary Era of Neoad-juvant Chemotherapy. J Gastroin-test Surg. Jan 2019;23(1):112-121. doi:10.1007/s11605-018-3966-8
  27. Wu JM, Ho TW, Kuo TC, et al. Gly-cemic Change After Pancreaticodu-odenectomy: A Population-Based Study. Medicine (Baltimore). Jul 2015;94(27):e1109. doi:10.1097/
  28. Perinel J, Mariette C, Dousset B, et al. Early Enteral Versus Total Par-enteral Nutrition in Patients Under-going Pancreaticoduodenectomy: A Randomized Multicenter Controlled Trial (Nutri-DPC). Ann Surg. Nov 2016;264(5):731-737. doi:10.1097/SLA.0000000000001896
  29. Lindkvist B, Phillips ME, Domin-guez-Munoz JE. Clinical, anthropo-metric and laboratory nutritional markers of pancreatic exocrine in-sufficiency: Prevalence and diag-nostic use. Pancreatology. Nov-Dec 2015;15(6):589-97. doi:10.1016/j.pan.2015.07.001
  30. Yamazaki S, Takayama T, Higaki T, et al. Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy. J Gas-troenterol. Jan 2016;51(1):55-62. doi:10.1007/s00535-015-1077-9

Published

2025-03-31

Issue

No. 1 (2025)

Section

Статьи